Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A-kinase anchoring protein 7 (AKAP7) is a member of the AKAP family of scaffolding proteins, characterized by their ability to bind the regulatory subunit (RII) of cAMP-dependent protein kinase A (PKA) and target the enzyme to specific intracellular compartments[1][2][3]. AKAP7 encodes several isoforms (including alpha, beta, and gamma) that localize PKA to distinct subcellular locations, thereby spatially organizing cAMP signaling. The major neuronal isoform (AKAP7α) anchors PKA at presynaptic sites in the hippocampus and other brain regions, where it is essential for anchoring PKA-RIIβ, regulating synaptic plasticity, and affecting learning and memory. The gamma isoform includes a phosphodiesterase-like domain, but its biochemical function is incompletely understood[4]. AKAP7 has emerging roles as a biomarker in certain diseases and is regarded as a key regulator of compartmentalized signal transduction[1][2][3][4].
(For AKAP inhibitors: disruption of PKA anchoring to AKAP7, thereby altering subcellular localization of PKA and its downstream signaling)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on A-kinase anchoring protein 7 (AKAP7).